Department of Urology, Nanjing First Hospital, Nanjing Medical University, No. 68 Changle Road, Nanjing, 210006, Jiangsu, People's Republic of China.
Department of Urology, Hefei Hospital Affiliated to Anhui Medical University (The Second People's Hospital of Hefei), Hefei, Anhui, People's Republic of China.
Stem Cell Res Ther. 2022 Feb 9;13(1):68. doi: 10.1186/s13287-022-02739-w.
Underactive bladder (UAB) is a common clinical problem but related research is rarely explored. As there are currently no effective therapies, the administration of adipose stromal vascular fraction (ad-SVF) provides a new potential method to treat underactive bladder.
Male Sprague-Dawley rats were induced by partial bladder outlet obstruction (PBOO) for four weeks and randomly divided into three groups: rats treated with PBS (Sham group); rats administrated with ad-SVF (ad-SVF group) and rats performed with ad-SVF spheroids (ad-SVFsp group). After four weeks, urodynamic studies were performed to evaluate bladder functions and all rats were sacrificed for further studies.
We observed that the bladder functions and symptoms of UAB were significantly improved in the ad-SVFsp group than that in the Sham group and ad-SVF group. Meanwhile, our data showed that ad-SVF spheroids could remarkably promote angiogenesis, suppress cell apoptosis and stimulate cell proliferation in bladder tissue than that in the other two groups. Moreover, ad-SVF spheroids increased the expression levels of bFGF, HGF and VEGF-A than ad-SVF. IVIS Spectrum small-animal in vivo imaging system revealed that ad-SVF spheroids could increase the retention rate of transplanted cells in bladder tissue.
Ad-SVF spheroids improved functions and symptoms of bladder induced by PBOO, which contributes to promote angiogenesis, suppress cell apoptosis and stimulate cell proliferation. Ad-SVF spheroids provide a potential treatment for the future patients with UAB.
膀胱活动低下症(UAB)是一种常见的临床问题,但相关研究很少。由于目前尚无有效的治疗方法,脂肪基质血管成分(ad-SVF)的给药为治疗膀胱活动低下症提供了一种新的潜在方法。
雄性 Sprague-Dawley 大鼠经部分膀胱出口梗阻(PBOO)诱导 4 周,随机分为三组:PBS 处理的大鼠(Sham 组);给予 ad-SVF 的大鼠(ad-SVF 组)和给予 ad-SVF 球体的大鼠(ad-SVFsp 组)。四周后,进行尿动力学研究以评估膀胱功能,所有大鼠均进行安乐死以进行进一步研究。
我们观察到,与 Sham 组和 ad-SVF 组相比,ad-SVFsp 组的 UAB 膀胱功能和症状明显改善。同时,我们的数据显示,ad-SVF 球体可显著促进膀胱组织中的血管生成,抑制细胞凋亡并刺激细胞增殖,优于其他两组。此外,ad-SVF 球体增加了 bFGF、HGF 和 VEGF-A 的表达水平高于 ad-SVF。IVIS Spectrum 小动物活体成像系统显示,ad-SVF 球体可增加膀胱组织中移植细胞的保留率。
ad-SVF 球体改善了 PBOO 诱导的膀胱功能和症状,有助于促进血管生成,抑制细胞凋亡并刺激细胞增殖。ad-SVF 球体为未来患有 UAB 的患者提供了一种潜在的治疗方法。